The impact of dry eye disease on visual function and patient satisfaction: A cross-sectional study

Yaser Ar Nasser Al Khafaji, Omar MahmoodInternational Journal of Medical Ophthalmology 2025 · DOI

Abstract

Background: Dry Eye Disease (DED) is a prevalent ocular condition characterized by tear film instability and ocular surface inflammation, leading to symptoms such as dryness, irritation, and visual disturbances. These symptoms can significantly impair visual function and reduce patient quality of life. Aim: To evaluate the impact of DED on visual function and patient satisfaction, and to investigate the associations between clinical signs, symptom severity, and quality-of-life measures in a cross-sectional cohort of 84 patients. Methods: A cross-sectional study was conducted from February 2024 to March 2025 involving 84 patients. Data collected included demographics, DED classification, Ocular Surface Disease Index (OSDI) scores, Visual Function Questionnaire (VFQ-25) scores, Tear Film Break-Up Time (TBUT), and Schirmer test results. Results: Mean age was 52.3±10.4 years. DED patients showed significantly lower visual function (VFQ-25 composite score 85.3±14.5) compared to the non-DED group (92.3±8.3). Conclusion: Dry eye disease significantly impairs visual function and daily activities, with symptom severity strongly predicting reduced quality of life.

Introduction

Dry Eye Disease (DED) is often dismissed as a minor nuisance, yet for millions, it is a debilitating condition. Historically, clinicians have relied heavily on "objective" measures like tear film stability and moisture production. However, there is a well-documented "clinical-symptom mismatch" where a patient’s eyes might appear healthy under a microscope while they suffer significant functional impairment. This study addresses this gap by investigating how DED impacts visual function—the ability to perform daily tasks like reading or driving—and overall patient satisfaction.

Methods and Study Population

The researchers conducted a cross-sectional study of 84 patients at ophthalmology and optometry clinics between February 2024 and March 2025. The assessment utilized a multi-modal strategy including clinical metrics (TBUT and Schirmer tests), symptom assessment via the Ocular Surface Disease Index (OSDI), and quality-of-life measures using the National Eye Institute Visual Function Questionnaire (VFQ-25).

Table 1: Patient demographics, symptom prevalence, and environmental triggers.

As detailed in the study population data, the cohort was predominantly female (60.7%) with a mean age of approximately 52 years. Dryness (85.7%) and grittiness (64.3%) were the most common complaints, with environmental factors like screen use (58.3%) and air conditioning (25.0%) identified as major contributing reasons for discomfort.

Key Results: Visual Function and Clinical Disparity

The study revealed a significant disconnect between clinical signs and functional impact. While traditional metrics showed clear differences—TBUT was 4.7 seconds in DED patients vs. 10.0 seconds in non-DED patients—regression analysis showed that total symptom scores were far stronger predictors of visual function impairment than clinical tests.

Table 2: Comparison of VFQ-25 subscale scores between DED and non-DED groups.

The subscale analysis highlights the broad reach of DED. Patients with DED scored lower across all domains, particularly in Ocular Pain and Mental Health. This suggests that the condition has a psychological footprint that traditional eye exams often miss, leading to feelings of frustration and helplessness.

Discussion and Insights

The Satisfaction Paradox

Interestingly, patient satisfaction did not correlate linearly with clinical metrics like tear production. A patient might show "improved" clinical signs but remain dissatisfied if symptoms persist. While patients were generally satisfied with the "Ease of Use" of treatments (72.6%), they were least satisfied with the "Duration of Relief" (47.6%), highlighting a major need for long-acting therapeutics.

Functional Impairment

DED significantly impacts high-stakes daily tasks. In this cohort, 59.5% of DED patients reported difficulty driving at night, and 51.2% struggled with computer use. The "collapse of visual function" associated with severe symptoms emphasizes the need for a holistic, patient-centered approach to treatment.

Conclusion

Dry Eye Disease significantly impairs visual function and daily activities, with symptom severity serving as the primary driver of reduced quality of life. While this study is limited by its cross-sectional design and sample size (n=84), it underscores the importance of treating the patient's lived experience rather than clinical metrics alone. Future longitudinal studies are needed to track disease progression and the long-term impact of psychosocial interventions.

Summary updated

Abstract

Background: (DED) it is a prevalent ocular condition characterized by tear film instability and ocular surface inflammation, leading to symptoms such as dryness, irritation, and visual disturbances. These symptoms can significantly impair visual function and reduce patient quality of life.Aim: To evaluate the impact of Dry Eye Disease on visual function and patient satisfaction, and to investigate the associations between clinical signs, symptom severity, and quality-of-life measures in a cross-sectional cohort of 84 patients.Methods: A cross-sectional study was conducted from February 2024 to March 2025 involving 84 patients where in this Study Data collected included demographics, DED classification (Definite, Suspected, No DED), Ocular Surface Disease Index (OSDI) scores, Visual Function Questionnaire (VFQ-25) composite and subscale scores, Tear Film Break-Up Time (TBUT), Schirmer test results, and patient satisfaction with treatment additinally Statistical analyses included descriptive statistics, chi-square tests for categorical associations, and linear regression to assess predictors of visual function.Results: in this study we, the results were found ( Mean age was 52.3±10.4 years, DED Classification: 40.5% had definite DED, 21.4% suspected DED (signs only), 19.0% suspected DED (symptoms only), and 19.0% no DED in addition to OSDI Scores were Mean score 26.8±18.7; 33.3% mild, 31.0% moderate, 35.7% severe symptoms however Visual Function (VFQ-25) was Mean composite score 85.3±14.5 overall, 85.3±14.5 in DED group vs. 92.3±8.3 in no DED group, TBUT was Mean 4.7±3.5 seconds in DED vs. 10.0±2.4 seconds in no DED, Schirmer Test was Mean 4.1±3.7 mm in DED vs. 12.2±4.5 mm in no DED and in finally we concourse dry eye disease significantly impairs visual function and daily activities, with symptom severity strongly predicting reduced quality of life.
BibTeX
@article{khafaji2025impact,
  author = {Yaser AR Nasser Al Khafaji and Omar Mahmood},
  title = {{The impact of dry eye disease on visual function and patient satisfaction: A cross-sectional study}},
  journal = {International Journal of Medical Ophthalmology},
  year = {2025},
  doi = {10.33545/26638266.2025.v7.i2a.242},
}
Figure